These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Non-hippo kinases: indispensable roles in YAP/TAZ signaling and implications in cancer therapy. Zhu J; Wu T; Lin Q Mol Biol Rep; 2023 May; 50(5):4565-4578. PubMed ID: 36877351 [TBL] [Abstract][Full Text] [Related]
3. Hippo pathway effectors YAP, TAZ and TEAD are associated with EMT master regulators ZEB, Snail and with aggressive phenotype in phyllodes breast tumors. Akrida I; Makrygianni M; Nikou S; Mulita F; Bravou V; Papadaki H Pathol Res Pract; 2024 Oct; 262():155551. PubMed ID: 39153238 [TBL] [Abstract][Full Text] [Related]
4. An overview of signaling pathways regulating YAP/TAZ activity. Heng BC; Zhang X; Aubel D; Bai Y; Li X; Wei Y; Fussenegger M; Deng X Cell Mol Life Sci; 2021 Jan; 78(2):497-512. PubMed ID: 32748155 [TBL] [Abstract][Full Text] [Related]
5. The Hippo Pathway in Prostate Cancer. Salem O; Hansen CG Cells; 2019 Apr; 8(4):. PubMed ID: 31018586 [TBL] [Abstract][Full Text] [Related]
6. YAP and TAZ play a crucial role in human erythrocyte maturation and enucleation. Damkham N; Lorthongpanich C; Klaihmon P; Lueangamornnara U; Kheolamai P; Trakarnsanga K; Issaragrisil S Stem Cell Res Ther; 2022 Sep; 13(1):467. PubMed ID: 36076260 [TBL] [Abstract][Full Text] [Related]
7. Roles of YAP/TAZ in ferroptosis. Magesh S; Cai D Trends Cell Biol; 2022 Sep; 32(9):729-732. PubMed ID: 35701310 [TBL] [Abstract][Full Text] [Related]
8. New insights into the ambivalent role of YAP/TAZ in human cancers. Luo J; Deng L; Zou H; Guo Y; Tong T; Huang M; Ling G; Li P J Exp Clin Cancer Res; 2023 May; 42(1):130. PubMed ID: 37211598 [TBL] [Abstract][Full Text] [Related]
9. TAZ Protein Accumulation Is Negatively Regulated by YAP Abundance in Mammalian Cells. Finch-Edmondson ML; Strauss RP; Passman AM; Sudol M; Yeoh GC; Callus BA J Biol Chem; 2015 Nov; 290(46):27928-38. PubMed ID: 26432639 [TBL] [Abstract][Full Text] [Related]
10. Role of the Hippo-YAP/TAZ Pathway in Epithelioid Hemangioendothelioma and its Potential as a Therapeutic Target. Suto H Anticancer Res; 2024 Oct; 44(10):4147-4153. PubMed ID: 39348982 [TBL] [Abstract][Full Text] [Related]
11. Role of YAP/TAZ in Energy Metabolism in the Heart. Kashihara T; Sadoshima J J Cardiovasc Pharmacol; 2019 Dec; 74(6):483-490. PubMed ID: 31815864 [TBL] [Abstract][Full Text] [Related]
12. Nuclear phosphoinositide signaling promotes YAP/TAZ-TEAD transcriptional activity in breast cancer. Jung O; Baek MJ; Wooldrik C; Johnson KR; Fisher KW; Lou J; Ricks TJ; Wen T; Best MD; Cryns VL; Anderson RA; Choi S EMBO J; 2024 May; 43(9):1740-1769. PubMed ID: 38565949 [TBL] [Abstract][Full Text] [Related]
13. YAP/TAZ at the Roots of Cancer. Zanconato F; Cordenonsi M; Piccolo S Cancer Cell; 2016 Jun; 29(6):783-803. PubMed ID: 27300434 [TBL] [Abstract][Full Text] [Related]
14. Physiological and pathological roles of the Hippo-YAP/TAZ signaling pathway in liver formation, homeostasis, and tumorigenesis. Nishina H Cancer Sci; 2022 Jun; 113(6):1900-1908. PubMed ID: 35349740 [TBL] [Abstract][Full Text] [Related]
15. Yes-Associated Protein and Transcriptional Coactivator with PDZ-Binding Motif in Cardiovascular Diseases. Li R; Huang W Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675179 [TBL] [Abstract][Full Text] [Related]
16. Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies. Kim MH; Kim J Cell Mol Life Sci; 2017 Apr; 74(8):1457-1474. PubMed ID: 27826640 [TBL] [Abstract][Full Text] [Related]
17. Induction of AP-1 by YAP/TAZ contributes to cell proliferation and organ growth. Koo JH; Plouffe SW; Meng Z; Lee DH; Yang D; Lim DS; Wang CY; Guan KL Genes Dev; 2020 Jan; 34(1-2):72-86. PubMed ID: 31831627 [TBL] [Abstract][Full Text] [Related]